Pfizer Q1 FY25: where the revenue came from and where it went
The whole income statement of Pfizer for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jan 1 – Mar 30, 2025
- Reported
- May 5, 2025
Revenue$13.7B
−8% year over year
Gross profit$10.9B
79% margin
Operating profit−$3.0B
−22% margin
Net profit$3.0B
22% margin
Net profit is larger than what operations earned, because the statement adds $5.9B below it, under Tax benefit and other.
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 13.7 | 100% | −8% |
| US | 8.4 | 61% | −12% |
| Developed markets | 3.2 | 23% | −1% |
| International emerging | 2.2 | 16% | +0% |
| Cost of revenue | −2.8 | 21% | |
| Gross profit | 10.9 | 79% margin | +2pp |
| SG&A | −3.0 | 22% | −1pp |
| Other | −10.8 | 79% | +0pp |
| Operating profit | −3.0 | −22% margin | +0pp |
| Tax benefit and other | 5.9 | ||
| Net profit | 3.0 | 22% margin | +1pp |
359 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest